(Press-News.org) April 11, 2013, Fort Lauderdale, Fla. -- Half of patients on high-dose, long-term opioid therapy had hormonal disturbances or signs of inflammation, while 100 percent reported improved pain control and mental outlook, new research shows. The results, reported today at the 29th Annual Meeting of the American Academy of Pain Medicine, present rare data on the effects of opioids beyond 10 years. Most clinical trials that examine opioid use are of short duration, and little is known about long-term outcomes, particularly in patients who suffer from noncancer pain.
The 40 patients included in the study were evaluated between July and October 2012. Each had been taking a high dose of opioid therapy, defined as more than 100 mg equivalence of morphine a day, for 10 or more years. Each complained of constant, debilitating pain that was classified as intractable, which is defined in California as "incurable by any known means." They had tried many non-opioid methods to try to control their pain. Every patient in the study also suffered from severe insomnia.
The patients were tested for serum cortisol, pregnenolone, corticotropin (ACTH), testosterone, erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP).
In addition, each patient took 2 written questionnaires. One measured improvements to 17 physiologic functions, including reading, hearing, concentration, memory, driving, sleep, movement, dressing and libido. The other questionnaire asked about depression, hopelessness and quality of life before and during opioid treatment.
All 40 patients reported improvements in depression, hopelessness and quality of life and sustained pain control that accompanied a stable opioid dosage. In addition, all patients reported improvements in at least 1 physiologic function. Categories in which at least 20 patients noted improvements were concentration (27 or 67.5 percent), walking (25 or 62.5 percent), appetite (20 or 50 percent) and movement (31 or 77.5 percent). Seventeen or 62.5 percent of patients reported improvements to sleeping.
Eight patients (20 percent) had hormonal suppression as follows: ACTH in 2 (5 percent), cortisol in 3 (7.5 percent), testosterone in 2 (5 percent) and pregnenolone in 4 (10 percent) of patients. Three patients (7.5 percent) had one or more serum elevations of a hormone as follows: ACTH in 1 (2.5 percent), cortisol in 2 (5 percent) and pregnenolone in 1 (2.5 percent). Nine patients (22.5 percent) had an elevated CRP or ESR.
"The high-dose opioid patients studied here greatly improved many physiologic functions and mental outlook," Forest Tennant, MD, PhD, study author and medical director of Veract Intractable Pain Clinic in West Covina, concluded, writing in a scientific poster. "Despite these improvements, 12 (30 percent) of patients had an elevated serum hormone level, an inflammatory marker, or both, suggesting the presence of an on-going painful, inflammatory process."
In addition, he wrote, the observed hormonal suppression was a significant complication.
Such findings are noteworthy as the U.S. Food and Drug Administration (FDA) and some states mull limits to opioid prescribing as a means to halt a rising tide of prescription drug abuse and overdose deaths. An FDA panel held a two-day public hearing in February to gather stakeholder testimony as it weighs labeling changes for opioid dosage, indication and treatment duration for noncancer pain.
###
Poster 135 - Improvement in Physiologic but not Hormonal Functions After 10 Years of Opioid Treatment
About AAPM
The American Academy of Pain Medicine is the premiere 2,400-member medical association for pain physicians and their treatment teams. Now in its 30th year of service, the Academy's mission is to optimize the health of patients in pain and eliminate it as a major public health problem by advancing the practice and specialty of pain medicine through education, training, advocacy and research. Information is available on the Academy's website at http://www.painmed.org. END
High-dose opioids disturb hormones long-term, but mental and physiologic function improves
2013-04-12
ELSE PRESS RELEASES FROM THIS DATE:
Full range of treatment settings and their effects on radiofrequency heat lesion size
2013-04-12
April 11, 2013, Fort Lauderdale, Fla. -- Changing the parameters used to deliver radiofrequency (RF) treatment greatly affects the size of the resulting heat lesion, researchers reported today in a study expected to deliver greater precision and more treatment options in interventional pain management. Results were presented at the 29th Annual Meeting of the American Academy of Pain Medicine.
"This is the most comprehensive study of radiofrequency heat lesion size for pain management to date," said the study's lead author, Eric Cosman Jr., PhD, scientific director of ...
New techniques reduce the complications of spinal cord stimulator implant
2013-04-12
April 11, 2013, Fort Lauderdale, Fla. -- Two innovative techniques in the placement of an implanted spinal cord stimulator (SCS) are expected to reduce common complications at the implant site, according to new research revealed today. Results from a case series highlighted an advanced lead anchoring technique and the emerging technology of using large single-port introducers, which enable placement of multiple neurostimulation leads through a single needle-entry point.
Neurostimulation leads are used in SCS therapy for the management of chronic pain. The researchers ...
Web-based tools found to enhance recruitment and prescreening for clinical pain trials
2013-04-12
April 11, 2013, Fort Lauderdale, Fla. -- Researchers are suggesting new ways to use existing Internet tools to recruit more study participants for clinical pain trials and to increase the likelihood they will remain throughout the study period. An innovative website allowed recruiters to reach out broadly to target and recruit potential subjects and to avoid many of the common difficulties of pain research, according to results presented today at the 29th Annual Meeting of the American Academy of Pain Medicine.
Research is important to establish which therapies are safe ...
Research shows promise for microwave ablation (MWA) to relieve painful bone and soft-tissue tumors
2013-04-12
April 11, 2013, Fort Lauderdale, Fla. -- First-of-its-kind research presented today showed microwave ablation (MWA) therapy cut pain in half for patients with painful bone and soft-tissue tumors and took less time to complete than radiofrequency ablation. Pain relief lasted over 4 months on average and up to 15 months in some patients, according to results reported at the 29th Annual Meeting of the American Academy of Pain Medicine.
Approximately 10,600 new cases of soft-tissue sarcoma and 2,570 new cases of bone sarcoma were diagnosed in the United States in 2009, according ...
Researchers measure reaction rates of second key atmospheric component
2013-04-12
LIVERMORE, Calif.— Researchers at Sandia National Laboratories' Combustion Research Facility, the University of Manchester, Bristol University, University of Southampton and Hong Kong Polytechnic have successfully measured reaction rates of a second Criegee intermediate, CH3CHOO, and proven that the reactivity of the atmospheric chemical depends strongly on which way the molecule is twisted.
The measurements will provide further insight into hydrocarbon combustion and atmospheric chemistry. A paper describing the research findings titled "Direct Measurements of Conformer-Dependent ...
Are 4 antenatal visits enough?
2013-04-12
Reanalysis of the World Health Organization's Antenatal Care Trial (WHOACT) shows that there is an increased risk of fetal death at between 32 and 36 weeks for women who have a reduced antenatal care package, finds research published in BioMed Central's open access journal Reproductive Health.
Original analysis of the WHOACT concluded that reducing antenatal visits of low risk women from eight to four was not detrimental to their or their babies' health and could cut costs. Based on this advice some countries have lowered the number of routine antenatal visits .
However, ...
Tiny wireless device shines light on mouse brain, generating reward
2013-04-12
AUDIO:
Scientists at Washington University School of Medicine in St. Louis and the University of Illinois in Urbana-Champaign, developed a tiny, light-emitting device that can activate and control neurons in the...
Click here for more information.
Using a miniature electronic device implanted in the brain, scientists have tapped into the internal reward system of mice, prodding neurons to release dopamine, a chemical associated with pleasure.
The researchers, at Washington ...
Sediba's ribcage and feet were not suitable for running
2013-04-12
Researchers at Wits University in South Africa, including Peter Schmid from the University of Zurich, have described the anatomy of a single early hominin in six new studies. Australopithecus sediba was discovered near Johannesburg in 2008. The studies in Science demonstrate how our two million year old ancestor walked, chewed and moved.
The fossils discovered four years ago in Malapa near Johannesburg show a mixture of primitive features of australopiths and advanced features of later human species. The researchers led by Prof Lee Berger of Wits University are therefore ...
Self-medication in animals much more widespread than believed
2013-04-12
ANN ARBOR—It's been known for decades that animals such as chimpanzees seek out medicinal herbs to treat their diseases. But in recent years, the list of animal pharmacists has grown much longer, and it now appears that the practice of animal self-medication is a lot more widespread than previously thought, according to a University of Michigan ecologist and his colleagues.
Animals use medications to treat various ailments through both learned and innate behaviors. The fact that moths, ants and fruit flies are now known to self-medicate has profound implications for the ...
Scientists discover gene mutation that causes children to be born without spleen
2013-04-12
The spleen is rarely noticed, until it is missing. In children born without this organ, that doesn't happen until they become sick with life-threatening bacterial infections. An international team of researchers led by scientists from Rockefeller's St. Giles Laboratory of Human Genetics and Infectious Diseases has now identified the defective gene responsible for this rare disorder. The findings, reported today in Science Express, may lead to new diagnostic tests and raises new questions about the role of this gene in the body's protein-making machinery.
Medically known ...